Dados do Trabalho

Título

CLINICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS OF AUTOIMMUNE ENCEPHALITIS IN PEDIATRICS: A SYSTEMATIC REVIEW REGARDING TREATMENT WITH IMMUNOBIOLOGICALS

Introdução

Autoimmune Encephalitis (AE) is a group of treatable inflammatory diseases of the CNS that affect people of all ages most of the time previously healthy. This condition occurs more frequently in immunocompetent than immunocompromised individuals and is characterized by prominent neuropsychiatric symptoms. Anti-NMDAR receptor encephalitis is one of the most common causes of AE. Patients with AE may present a variety of movement disorders, such as ataxia, dystonia, myoclonus, and orofacial dyskinesia. Seizures are the most common symptom and different types can be observed, from focal to generalized, including refractory status epilepticus.

Objetivo

This study aims, through a systematic review, to list the main aspects of autoimmune encephalitis in pediatrics.

Método

A systematic review was performed based on the PRISMA recommendations. In addition, the MEDLINE, LILACS and SciELO databases were used, as well as consultations with recent editions of relevant journals on the subject, such as the Neuropsychiatry Archives. Articles with full texts from the last 7 years, in English, Spanish and Portuguese and dealing with the issue in the pediatric age group were included.

Resultados e Conclusões

The discovery of the class of autoimmune encephalitis has changed the diagnostic and therapeutic approach to many neurological or psychiatric syndromes previously considered idiopathic. Physicians should be aware of the different laboratory evaluation methods available, as well as the proper interpretation of results. Encephalitis should be considered in the face of the sudden onset of neuropsychiatric symptoms with a variable spectrum, as early diagnosis and therapy are key factors. The treatment scheme is based on observational studies and clinical experience with anti-NMDAR encephalitis, as it is the most prevalent and most studied type. Therefore, the conduct must be individualized for each patient, considering age, whether there is a tumor and the severity of manifestations. Cases that do not require intensive care and do not have an underlying tumor are also associated with a better prognosis.

Palavras Chave

Pediatrics, Children, Autoimmunity; Encephalitis; Encephalopathies

Declaração de conflito de interesses de TODOS os autores

Nenhum conflito de interesses a ser declarado de nenhum dos autores

Fonte de Fomento (se houver)

Nenhuma

Referências (se houver)

Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R. Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuro-Psiquiatr. janeiro de 2018;76(1):41–9.
Fernandes BLM, Webber J, Vasconcelos LGA, Vasconcelos MM. Autoimmune encephalitides. Residência Pediátrica. :9.
Lancet Neurol. A clinical approach to diagnosis of autoimmune encephalitis. Prof. Francesc Graus, MD, et.al. 2016 April; 15(4): 391–404.
Dalmau J, Rosenfeld MR, DeAngelis LM, Eichler AF. Paraneoplastic and autoimmune encephalitis. Uptodate. 2017;(December):1–22.
Krogstad P, Hardarson HS. Acute viral encephalitis in children: Clinical manifestations and diagnosis.UptoDate. 2021; (June): 1- 23.
Galvão, T F, Pansani, T S A, Harrad, D. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. Serv. Saúde, Brasília , v. 24, n. 2, p. 335-342, June 2015 .
Gregory CP, Nóbrega-Júnior AW, Lin K. Encefalites autoimunes – abordagem prática para situações de recursos limitados. Bol Curso Med UFSC 2019; v. 5 n. 2 (2019): Maio.
Ferreira J.A, Peixoto S, Carrilho I, Martins V. Encefalite autoimune anti receptor N-metil-D-aspartato: relato de dois casos. Sei Med. 2018; 28 (2): ID:29534.
Dalmau J, Rosenfeld MR. Overview of paraneoplastic syndromes of the nervous system Uptodate. 2021;(October):1–49.
Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med 2018; 378:840.

Área

Neuroimunologia, esclerose múltipla e outras doenças desmielinizantes